Omsk hemorrhagic fever (OHF) is an acute viral disease caused by a virus belonging to the rodentiovirus family. The pathology is characterized by an acute onset, high mortality, and manifestations of hemorrhagic syndrome. The infection is transmitted through tick bites, contact with infected animals, and through direct contact with the biological fluids of sick people. Symptoms of the disease can vary from mild forms with a slight increase in temperature and headache to severe cases with massive hemorrhages, dysfunction of organs and systems. OHF is a pressing problem for certain regions of Russia and the CIS countries, especially in the Omsk Region, where cases of natural foci have been registered.
History of the disease and interesting historical facts
The history of Omsk hemorrhagic fever begins in 1940, when the first cases of the disease were registered in the Omsk region. The virus causing this fever was isolated in 1969, which contributed to a deeper understanding of the pathogenesis and epidemiology of this disease. Since then, cases of OHF have been recorded in various regions, but the Omsk region remains the main natural focus. Interestingly, in 1990-1991, mass infection occurred in Omsk and neighboring areas, which led to the need for active epidemiological monitoring and vaccination of the population. Today, not only the virus itself is being studied, but also its interaction with the ecosystem, which allows for the development of new prevention methods.
Epidemiology
According to the World Health Organization, Omsk hemorrhagic fever has been registered mainly in the Siberian Federal District of Russia over the past decades. According to statistics, over the past 10 years, the average number of cases of the disease has been from 50 to 150 per year, with peaks of up to 300 cases during epidemics. There is no gender predisposition, but an increased risk of infection is observed in people working in agriculture and forestry, as well as in rural areas. It is important to note that most cases are registered in the summer, which is due to the activity of carriers.
Genetic predisposition to this disease
At present, genetic predisposition to Omsk hemorrhagic fever has not been established as a significant risk factor. However, the influence of genes associated with the immune response on the development and course of the disease is being studied. Of particular interest are the genes responsible for the synthesis of the interferon inducer, as well as the genes encoding receptors for various viruses. As part of scientific research, it was proposed to study polymorphisms in genes associated with the inflammatory response and protection against viral infection. It should be noted that most of the population in endemic regions regularly contacts the virus, which can lead to the formation of an immune response.
Risk factors for the development of this disease
Risk factors that contribute to the development of Omsk hemorrhagic fever include both physical and chemical. Physical factors include:
- Contact with nature, especially during tick season.
- Work in forests or agriculture where infection through tick bites is possible.
- Spending time in high-risk areas such as taiga forests.
Chemical risk factors include the use of pesticides, which may increase the body's susceptibility if there is simultaneous contact with the virus. Immunodeficiency conditions, which may lead to more severe forms of the disease, are also considered potential risk factors.
Diagnosis of this disease
Diagnosis of Omsk hemorrhagic fever includes several key stages. The main symptoms of the disease may vary, but the most common are:
- High temperature (up to 40°C).
- Headache and myalgia.
- Ulcerative hemorrhages and exanthema.
- Hepatomegaly and splenomegaly.
Laboratory tests include serologic tests for the presence of specific IgM and IgG antibodies to the virus. Additional tests may include polymerase chain reaction (PCR) to detect viral RNA and microscopy to detect specific antigens. Radiologic examinations may help in assessing the condition of organs and systems. Differential diagnosis should include other hemorrhagic fevers, such as hemorrhagic fever with renal syndrome, yellow fever, and viral infections associated with hemorrhagic syndrome.
Treatment
Treatment of Omsk hemorrhagic fever is based on complex therapy. As a general treatment, measures aimed at maintaining homeostasis can be used, such as:
- Rehydration therapy (intravenous administration of solutions to replenish fluid volume).
- Symptomatic therapy to relieve pain and reduce temperature.
- Monitoring vital signs and laboratory data.
Pharmacological treatment includes the use of antiviral drugs such as ribavirin, although its effectiveness against Omsk hemorrhagic fever requires further research. It is important to note that antibiotics are not indicated, as the disease is viral in nature. Surgical treatment may be required in case of complications such as ascites or hematomas requiring drainage. Supportive therapy aimed at correcting water-electrolyte imbalance and oxygen starvation is also important.
List of medications used to treat this disease
The drugs used in the treatment of Omsk hemorrhagic fever include:
- Ribavirin is an antiviral drug.
- Paracetamol – to reduce fever and relieve pain.
- Rehydration medications (solutions such as Ringer's and Crystalloids are recommended).
- Glucocorticosteroids – in case of massive hemorrhagic syndrome.
It is important that the choice of drugs and treatment regimens should be based on the individual characteristics of the patient and the course of the disease.
Disease monitoring
Monitoring of the patient's condition with Omsk hemorrhagic fever is carried out through regular control stages, including:
- Establishing a clinical diagnosis at an early stage.
- Assessment of the condition in dynamics based on laboratory parameters.
- Regular assessments of liver and kidney function.
The prognosis is favorable in most cases, but severe forms can lead to complications such as acute renal failure and hepatitis, which require intensive care. Complications can develop against the background of massive hemorrhagic syndrome and require special attention and specialized care.
Age-related features of the disease
In people under 18 years of age, the disease may proceed in a milder form, but in infants and newborns, the likelihood of a severe course increases significantly. In older people, valve epic often leads to more pronounced hemorrhagic symptoms and severe organ dysfunction. Along with this, in people over 65 years of age, the risk of developing concomitant diseases increases, which can worsen the prognosis.
Questions and Answers
- How is Omsk hemorrhagic fever transmitted? The disease is transmitted through the bites of ixodid ticks, as well as through contact with infected animals and their excrements.
- What are the main symptoms of Omsk hemorrhagic fever? The main symptoms include high fever, headache, myalgia, exanthema and hemorrhagic syndrome.
- What laboratory tests are needed for diagnosis? The most important tests are serological tests for the presence of antibodies, PCR to detect viral RNA and a complete blood count.
- What treatment is used for patients with Omsk hemorrhagic fever? Treatment includes supportive care, rehydration therapy, antiviral drugs and symptomatic treatment.
- What is the prognosis for the disease? The prognosis depends on the severity of the disease, but in most cases, if you see a doctor in a timely manner, it is favorable.
